In order to shed further light on this matter, the objective of this study was to assess the correlation between widely studied polymorphisms in the CDKN2A gene and the risk of pediatric ALL through a comprehensive meta-analysis including all relevant case-control studies. Here, CDKN2A is linked to acute lymphoblastic leukemia.